Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study (vol 64, pg 139, 2023)

被引：2
作者：
Knupp, Kelly G.
Scheffer, Ingrid E.
Ceulemans, Berten
Sullivan, Joseph
Nickels, Katherine C.
Lagae, Lieven
Guerrini, Renzo
Zuberi, Sameer M.
Nabbout, Rima
Riney, Kate
Agarwal, Anupam
Lock, Michael
Dai, David
Farfel, Gail M.
Galer, Bradley S.
Gammaitoni, Arnold R.
Polega, Shikha
Davis, Ronald
Gil-Nagel, Antonio
机构：
来源：
EPILEPSIA | 2024年 / 65卷 / 07期
关键词：
D O I：
10.1111/epi.17999
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2179 / 2179
页数：1
相关论文
共 1 条
[1]   Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study [J].
Knupp, Kelly G. ;
Scheffer, Ingrid E. ;
Ceulemans, Berten ;
Sullivan, Joseph ;
Nickels, Katherine C. ;
Lagae, Lieven ;
Guerrini, Renzo ;
Zuberi, Sameer M. ;
Nabbout, Rima ;
Riney, Kate ;
Agarwal, Anupam ;
Lock, Michael ;
Dai, David ;
Farfel, Gail M. ;
Galer, Bradley S. ;
Gammaitoni, Arnold R. ;
Polega, Shikha ;
Davis, Ronald ;
Gil-Nagel, Antonio .
EPILEPSIA, 2023, 64 (01) :139-151
1